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ABSTRACT 
In many studies, green tea epigallocatechin-3-gallate (EGCG) has already shown its therapeutic 
effects in colorectal cancer cells (CRC). However, its mechanism of actions in CRC is poorly 
elucidated. Hence, this study attempts to elucidate the mechanism of actions of green tea ECGG 
via iron chelation activity in CRC. In order to investigate this property, HT-29 cell lines (CRC) 
were treated with EGCG for 24 h, 48 h, and 72 h. From western blot analysis, EGCG had 
upregulated transferrin receptor (TfR) protein and downregulated Ferritin-H (FtH) protein 
indicating that iron chelation activity has occurred in CRC. Meanwhile, the molecular docking 
study demonstrated that EGCG is able to strongly interact the ferritin protein with a high 
binding affinity (−7.3 kcal/mol) via strong hydrogen bindings to glutamic acid 64 and lysine 
71; two moderate hydrogen bindings to asparagine 74 and a hydrophobic interaction to the 
hydrophobic pocket of lysine 71. The strong interaction predicted between EGCG to ferritin 
may lead to inhibition of ferritin by EGCG, thus supporting the downregulation of FtH 
observed in in vitro studies. Molecular docking study of TfR to EGCG cannot be modulated 
based on the in vitro results. In conclusion, EGCG possesses iron chelator property in CRC and 
this potential could be further exploited for CRC treatment. 
